Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             28 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Activity of the dolastatin analogue, LU103793, in malignant melanoma J. Smyth
 2001
 12 4 p. 509-511
3 p.
 artikel
2 A multicenter randomized clinical trial comparing paclitaxelcisplatinetoposide versus cisplatinetoposide as first-line treatment in patients with small-cell lung cancer D. Mavroudis
 2001
 12 4 p. 463-470
8 p.
 artikel
3 A phase II study of gemcitabine and cisplatin combination as induction chemotherapy for untreated locally advanced cervical carcinoma A. Dueñas-Gonzalez
 2001
 12 4 p. 541-547
7 p.
 artikel
4 A phase II trial of irinotecan (CPT-11) for unresectable biliary tree carcinoma P. M. Sanz-Altamira
 2001
 12 4 p. 501-504
4 p.
 artikel
5 A. Tefferi (ed), Primary Hematology T. Barbui
 2001
 12 4 p. 430-430
1 p.
 artikel
6 Carcinoma of an unknown primary site: A chemotherapy strategy based on histological differentiation results of a prospective study M. Saghatchian
 2001
 12 4 p. 535-540
6 p.
 artikel
7 c-erbB-2 oncoprotein overexpression identifies a subgroup of estrogen receptor positive (ER+) breast cancer patients with poor prognosis A. E. Pinto
 2001
 12 4 p. 525-533
9 p.
 artikel
8 Chemotherapy in elderly patients with colorectal cancer C.-H. Köhne
 2001
 12 4 p. 435-442
8 p.
 artikel
9 Clinical outcome after front-line intensive sequential chemotherapy (ISC) in patients with aggressive non-Hodgkins lymphoma and high-risk international prognostic index (IPI 3): Final analysis of survival in two consecutive ISC trials R. Bouabdallah
 2001
 12 4 p. 513-517
5 p.
 artikel
10 Dose escalation of cytotoxic drugs using haematopoietic growth factors: A randomized trial to determine the magnitude of increase provided by GM-CSF M. Pfreundschuh
 2001
 12 4 p. 471-477
7 p.
 artikel
11 E400P in advanced seminoma of good prognosis according to the International Germ Cell Cancer Collaborative Group (IGCCCG) classification: The Spanish Germ Cell Cancer Group experience J. A. Arranz Arija
 2001
 12 4 p. 487-491
5 p.
 artikel
12 FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: Comparison with spiral CT C. Franzius
 2001
 12 4 p. 479-486
8 p.
 artikel
13 Geographical disparities in self-reported use of mammography and breast self-examination according to the Swiss Health Survey P. Wanner
 2001
 12 4 p. 573-574
2 p.
 artikel
14 Human and fruit fly genome nucleotide sequences hit the press as similar: And so what...; Cheap drugs? Part 1: A challenge to multinationals and to patent rights; Embryo (cells) for research; Argentina loses a pioneer;A fighter against environmentally induced cancer passes away; Cheap drugs? Part 2: WHO intervenes;Italy: Colleagues will assure the pain does not return;Perhaps not everyone knows that... 2001
 12 4 p. 423-429
7 p.
 artikel
15 Intensified chemotherapy supported by DMSO-free peripheral blood progenitor cells in breast cancer patients L. Del Mastro
 2001
 12 4 p. 505-508
4 p.
 artikel
16 Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkins lymphoma A. Tulpule
 2001
 12 4 p. 457-462
6 p.
 artikel
17 Management of carcinoma of unknown primary site (CUP), any changes? H. H. Hansen
 2001
 12 4 p. 431-432
2 p.
 artikel
18 Oxaliplatin and protracted continuous 5-fluorouracil infusion in patients with pretreated advanced colorectal carcinoma A. Martoni
 2001
 12 4 p. 519-524
6 p.
 artikel
19 Palliative medicine and medical oncology M. Maltoni
 2001
 12 4 p. 443-450
8 p.
 artikel
20 Phase I dose escalation study of topotecan combined with alternating schedules of paclitaxel and carboplatin in advanced solid tumors F. R. Dunphy
 2001
 12 4 p. 549-555
7 p.
 artikel
21 Phase III study of pegylated liposomal cisplatin (SPI-077TM) in patients with inoperable head and neck cancer K. J. Harrington
 2001
 12 4 p. 493-496
4 p.
 artikel
22 Phase II trial of liposomal daunorubicin in malignant pleural mesothelioma J. P. C. Steele
 2001
 12 4 p. 497-499
3 p.
 artikel
23 Primary papillary serous carcinoma of the peritoneum in a man E. Shmueli
 2001
 12 4 p. 563-567
5 p.
 artikel
24 Prognostic factors and treatment effects on survival in acute myeloid leukemia of M6 subtype: A retrospective study of 54 cases A. Colita
 2001
 12 4 p. 451-455
5 p.
 artikel
25 Safe administration of irinotecan, oxaliplatin and raltitrexed in a DPD-deficient patient with metastatic colon cancer J. Volk
 2001
 12 4 p. 569-571
3 p.
 artikel
26 Single-agent gemcitabine in patients with resistant small-cell lung cancer I. van der Lee
 2001
 12 4 p. 557-561
5 p.
 artikel
27 The role of mitomycin C in the treatment of patients with advanced colorectal cancer resistant to 5-fluorouracil-folinic acid chemotherapy S. A. Grumett
 2001
 12 4 p. 575-575
1 p.
 artikel
28 What can we expect from liposomal drugs? C. Dumontet
 2001
 12 4 p. 433-434
2 p.
 artikel
                             28 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland